Evidence map›Paper›PMID 25886562›Full record

ArticleRetrovirology2015

Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection.

Michelle Vincendeau, Ingmar Göttesdorfer, Julia M H Schreml, Armand G Ngounou Wetie, Jens Mayer, Alex D Greenwood, Markus Helfer, Susanne Kramer, Wolfgang Seifarth, Kamyar Hadian and 2 more

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
8.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Human endogenous retroviruses and exogenous viral infections.Frontiers in cellular and infection microbiology · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Michelle VincendeauInstitute of Virology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. michelle.vincendeau@helmholtz-muenchen.de.
Ingmar GöttesdorferInstitute of Virology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. ingmar.goettesdorfer@helmholtz-muenchen.de.
Julia M H SchremlDepartment of Hematology and Oncology, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany. julia.schreml@uk-koeln.de.
Armand G Ngounou WetieInstitute of Virology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. ngounoa@clarkson.edu.
Jens MayerDepartment of Human Genetics, Center of Human and Molecular Biology, Medical Faculty, University of Saarland, Homburg, Germany. jens.mayer@uniklinik-saarland.de.
Alex D GreenwoodDepartment of Wildlife Diseases, Leibniz Institute for Zoo and Wildlife Research, Berlin, Germany. greenwood@izw-berlin.de.
Markus HelferInstitute of Virology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. markus.helfer@helmholtz-muenchen.de.
Susanne KramerInstitute of Virology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. susanne-kramer@gmx.com.
Wolfgang SeifarthDepartment of Hematology and Oncology, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany. wolfgang.seifarth@medma.uni-heidelberg.de.
Kamyar HadianResearch Unit Cellular Signal Integration, Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. kamyar.hadian@helmholtz-muenchen.de.
Ruth Brack-WernerInstitute of Virology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. brack@helmholtz-muenchen.de.
Christine Leib-MöschInstitute of Virology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. leib@helmholtz-muenchen.de.
Helmholtz Zentrum München · DEHeidelberg University · DELeibniz Institute for Zoo and Wildlife Research · DESaarland University · DEUniversity Hospital Heidelberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe human genome contains multiple LTR elements including human endogenous retroviruses (HERVs) that together account for approximately 8-9% of the genomic DNA. At least 40 different HERV groups have been assigned to three major HERV classes on the basis of their homologies to exogenous retroviruses. Although most HERVs are silenced by a variety of genetic and epigenetic mechanisms, they may be reactivated by environmental stimuli such as exogenous viruses and thus may contribute to pathogenic conditions. The objective of this study was to perform an in-depth analysis of the influence of HIV-1 infection on HERV activity in different cell types.

resultsA retrovirus-specific microarray that covers major HERV groups from all three classes was used to analyze HERV transcription patterns in three persistently HIV-1 infected cell lines of different cellular origins and in their uninfected counterparts. All three persistently infected cell lines showed increased transcription of multiple class I and II HERV groups. Up-regulated transcription of five HERV taxa (HERV-E, HERV-T, HERV-K (HML-10) and two ERV9 subgroups) was confirmed by quantitative reverse transcriptase PCR analysis and could be reversed by knock-down of HIV-1 expression with HIV-1-specific siRNAs. Cells infected de novo by HIV-1 showed stronger transcriptional up-regulation of the HERV-K (HML-2) group than persistently infected cells of the same origin. Analysis of transcripts from individual members of this group revealed up-regulation of predominantly two proviral loci (ERVK-7 and ERVK-15) on chromosomes 1q22 and 7q34 in persistently infected KE37.1 cells, as well as in de novo HIV-1 infected LC5 cells, while only one single HML-2 locus (ERV-K6) on chromosome 7p22.1 was activated in persistently infected LC5 cells.

conclusionsOur results demonstrate that HIV-1 can alter HERV transcription patterns of infected cells and indicate a correlation between activation of HERV elements and the level of HIV-1 production. Moreover, our results suggest that the effects of HIV-1 on HERV activity may be far more extensive and complex than anticipated from initial studies with clinical material.

Indexed as

Transcription, GeneticVirus ActivationCell LineEndogenous RetrovirusesGene Expression ProfilingHIV-1HIV InfectionsHumansMicroarray Analysis

Identifiers

PMID25886562
PMCPMC4375885
OpenAlexW2057519261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.